The determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for heparin treated patients with acute coronary syndromes: a review of GUSTO-IIb - Lee, MS; Wali, AU; Menon, V (J Thromb Thrombolysis, 2002)
et al.